A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Thyroglobulin
Lacosamide
The risk or severity of adverse effects can be increased when Lacosamide is combined with Lithium carbonate.
Thyroglobulin
YKP-1358
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Lithium carbonate.
Thyroglobulin
Lumateperone
The risk or severity of adverse effects can be increased when Lumateperone is combined with Lithium carbonate.
Thyroglobulin
Gantacurium
The risk or severity of adverse effects can be increased when Gantacurium is combined with Lithium carbonate.
Thyroglobulin
BL-1020
The risk or severity of adverse effects can be increased when BL-1020 is combined with Lithium carbonate.
Thyroglobulin
PRX-08066
The risk or severity of adverse effects can be increased when PRX-08066 is combined with Lithium carbonate.
Thyroglobulin
Naluzotan
The risk or severity of adverse effects can be increased when Naluzotan is combined with Lithium carbonate.
Thyroglobulin
Naronapride
The risk or severity of adverse effects can be increased when Naronapride is combined with Lithium carbonate.
Thyroglobulin
Tetrodotoxin
The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Lithium carbonate.
Thyroglobulin
APD791
The risk or severity of adverse effects can be increased when APD791 is combined with Lithium carbonate.
Thyroglobulin
Renzapride
The risk or severity of adverse effects can be increased when Renzapride is combined with Lithium carbonate.
Thyroglobulin
Pagoclone
The risk or severity of adverse effects can be increased when Pagoclone is combined with Lithium carbonate.
Thyroglobulin
Bifeprunox
The risk or severity of adverse effects can be increased when Bifeprunox is combined with Lithium carbonate.
Thyroglobulin
Cilansetron
The risk or severity of adverse effects can be increased when Cilansetron is combined with Lithium carbonate.
Thyroglobulin
Rapacuronium
The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lithium carbonate.
Thyroglobulin
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Lithium carbonate.
Thyroglobulin
Urethane
The risk or severity of adverse effects can be increased when Urethane is combined with Lithium carbonate.
Thyroglobulin
Nomifensine
The risk or severity of adverse effects can be increased when Nomifensine is combined with Lithium carbonate.
Thyroglobulin
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Lithium carbonate.
Thyroglobulin
Valpromide
The risk or severity of adverse effects can be increased when Valpromide is combined with Lithium carbonate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3